Hello, everyone, and how are you today? We are hustling about delivering this or that short person to assorted destinations. And, of course, we are preparing for another day of interesting conversations and reading. To cope, we are, as always, brewing multiple cups of stimulation. Please join us. Meanwhile, here are some items from around your world. Hope your days goes well and see you soon...
Glaxo Campus Building Catches Fire (Patch)
Supreme Court Lets Class Action Against Baycol Proceed (Associated Press)
Glaxo Rotavirus Vaccine Linked To Bowel Disorder (WebMd)
FDA Accepts Novartis Application For Broader Menveo Use (Reuters)
Bristol-Myers Gets FDA OK On New Transplant Drug (Associated Press)
Lundbeck To File Alcoholism Drug In Europe This Year (Pharma Times)
How 'Club Drug' Ketamine Lifts Depression Quickly (Time)
Sanofi Hunts For Drugs Against Hearing Loss (Reuters)
Effort Under Way To Repeal Massachusetts Gift Ban (Boston Globe)
EDITOR’S NOTE: Please check this post for updates throughout the morning